One small direct listing is currently scheduled for the week ahead, but movement in the pipeline points to a wave of launches in the short holiday week. We see up to eight companies that could start their roadshows. A few recent filers are primed to launch:...read more
Two multibillion-dollar names joined the pipeline in the final week of the IPO market’s summer doldrums. SoftBank-backed power and data center developer SB Energy (SBE) signals that the dominant theme of the 2026 IPO market, AI infrastructure, will...read more
ADARx Pharmaceuticals, a Phase 3 biotech developing siRNA therapies for various diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering. ADARx Pharmaceuticals is focused on developing next-generation small interfering...read more
US IPO Week Ahead: IPO calendar primed for post-Labor Day launches
One small direct listing is currently scheduled for the week ahead, but movement in the pipeline points to a wave of launches in the short holiday week. We see up to eight companies that could start their roadshows. A few recent filers are primed to launch:...read more
US IPO Weekly Recap: SB Energy and Oura headline a pickup in filings
Two multibillion-dollar names joined the pipeline in the final week of the IPO market’s summer doldrums. SoftBank-backed power and data center developer SB Energy (SBE) signals that the dominant theme of the 2026 IPO market, AI infrastructure, will...read more
siRNA biotech ADARx Pharmaceuticals files for a $100 million IPO
ADARx Pharmaceuticals, a Phase 3 biotech developing siRNA therapies for various diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering. ADARx Pharmaceuticals is focused on developing next-generation small interfering...read more